What is Clinical Regulatory Writing? Clinical Regulatory Writing is a highly specialized type of medical writing which facilitates the development, approval and post marketing surveillance of drugs and medical devices. It includes developing the necessary materials needed by international health regulators, including the FDA, EMA, and MHRA, when performing the clinical trial and regulatory submission… Continue reading What is Clinical Regulatory Writing
Category: Regulatory
What is a Drug Regulatory Authority
What is a Drug Regulatory Authority? In the pharmaceutical sector, integrity of drug development, production, and distribution matters most. The main role of Drug Regulatory Authority (DRA) is to ensure that the pharmaceutical product is of the set standard of safety, quality and efficacy.
What is Claim Substantiation
What is Claim Substantiation? Claim substantiation in pharmaceutical business is a very important process whereby all claims that are related to products such as therapeutic, preventive and supportive ones are supported by reliable scientific facts. The practice is not only a regulatory liability but also a pillar of an ethical marketing practice and patient safety.
What is Clinical Regulatory Writing
What is Clinical Regulatory Writing? Clinical Regulatory Writing is a highly specialized type of medical writing which facilitates the development, approval and post marketing surveillance of drugs and medical devices. It includes developing the necessary materials needed by international health regulators, including the FDA, EMA, and MHRA, when performing the clinical trial and regulatory submission… Continue reading What is Clinical Regulatory Writing
What is Aggregate Reporting
What is Aggregate Reporting? In the pharmaceutical industry, patient safety goes hand-in-hand with regulatory compliance. Aggregate Reporting is one of the most important instruments that allow this, a methodical way to analyze data on drug safety over time.
What is an Individual Case Safety Report (ICSR)
What is an Individual Case Safety Report (ICSR)? Drug safety after approval is an important issue in the pharmaceutical industry. Individual Case Safety Reports (ICSRs) are documents which report adverse events in patients and can be used to identify risks and comply with regulations. As a core element of pharmacovigilance, ICSRs support global health decisions.
What is Package Inserts (PIs)
What is Package Inserts (PIs) ? Package Inserts (PIs) are regulatory documents that are packaged with prescription medications, providing healthcare practitioners with crucial details of the safe and effective usage of the medications. PIs, approved by world health organizations, also include scientific information on indications, dosage, warnings, etc.
What Are Safety Labeling Changes (SLC)
What Are Safety Labeling Changes (SLC)? In the world of pharmaceuticals, drug safety doesn’t end at approval. Once a medication is on the market, its real-world use often uncovers new safety information that wasn’t visible during clinical trials. This is where Safety Labeling Changes (SLC) apply.
What is Structured Product Monograph (SPM)
In a digital-first healthcare ecosystem, clarity, consistency, and easy access to information about drugs are more important than before. That’s where the Structured Product Monograph (SPM) comes in a modern, structured, and machine-readable version of a traditional product monograph.
What Is Structured Product Labeling (SPL)
Drug information is important in highly regulated world of pharmaceuticals because use of incorrect information may result in an injurious outcome. The Structured Product Labeling (SPL) is one of the basic instruments that the U.S. Food and Drug Administration (FDA) employs in this undertaking.
